Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

688 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
Lebwohl MG, Kircik LH, Moore AY, Stein Gold L, Draelos ZD, Gooderham MJ, Papp KA, Bagel J, Bhatia N, Del Rosso JQ, Ferris LK, Green LJ, Hebert AA, Jones T, Kempers SE, Pariser DM, Yamauchi PS, Zirwas M, Albrecht L, Devani AR, Lomaga M, Feng A, Snyder S, Burnett P, Higham RC, Berk DR. Lebwohl MG, et al. JAMA. 2022 Sep 20;328(11):1073-1084. doi: 10.1001/jama.2022.15632. JAMA. 2022. PMID: 36125472 Free PMC article.
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
Lebwohl MG, Breneman DL, Goffe BS, Grossman JR, Ling MR, Milbauer J, Pincus SH, Sibbald RG, Swinyer LJ, Weinstein GD, Lew-Kaya DA, Lue JC, Gibson JR, Sefton J. Lebwohl MG, et al. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):590-6. doi: 10.1016/s0190-9622(98)70008-8. J Am Acad Dermatol. 1998. PMID: 9777766 Clinical Trial.
Finasteride in the treatment of men with frontal male pattern hair loss.
Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D, Rapaport M, Kang S, Kelly T, Pariser D, Webster G, Hordinsky M, Rietschel R, Katz HI, Terranella L, Best S, Round E, Waldstreicher J. Leyden J, et al. J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):930-7. doi: 10.1016/s0190-9622(99)70081-2. J Am Acad Dermatol. 1999. PMID: 10365924 Clinical Trial.
AAD consensus statement on psoriasis therapies.
Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmerman G; AAD. Callen JP, et al. J Am Acad Dermatol. 2003 Nov;49(5):897-9. doi: 10.1016/s0190-9622(03)01870-x. J Am Acad Dermatol. 2003. PMID: 14576671 Review. No abstract available.
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.
Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D; Efalizumab Study Group. Lebwohl M, et al. N Engl J Med. 2003 Nov 20;349(21):2004-13. doi: 10.1056/NEJMoa030002. N Engl J Med. 2003. PMID: 14627785 Free article. Clinical Trial.
Psoriasis.
Koo J, Lee E, Lee CS, Lebwohl M. Koo J, et al. J Am Acad Dermatol. 2004 Apr;50(4):613-22. doi: 10.1016/j.jaad.2003.11.046. J Am Acad Dermatol. 2004. PMID: 15034513 No abstract available.
688 results